title: Therapy. New mechanisms of IVIg.
authors.forename: Emma
authors.initials: E
authors.lastname: Leah
mesh_terms: D000818:Animals; D000936:Antigen-Antibody Complex / Q000378:metabolism*; D051546:Cyclooxygenase 2 / Q000378:metabolism*; D003713:Dendritic Cells / Q000166:cytology* / Q000378:metabolism*; D015232:Dinoprostone / Q000378:metabolism*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000494:pharmacology*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000037:antagonists & inhibitors* / Q000187:drug effects*; D050378:T-Lymphocytes, Regulatory / Q000166:cytology*; D051193:Toll-Like Receptors / Q000378:metabolism*
chemical_list: D000936:Antigen-Antibody Complex; D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous; D016898:Interferon-alpha; D051193:Toll-Like Receptors; D051546:Cyclooxygenase 2; D015232:Dinoprostone
references.citation: Arthritis Rheum. 2013 Oct;65(10):2713-23
references.pmid: 23840006
references.citation: Blood. 2013 Aug 22;122(8):1419-27
references.pmid: 23847198